Brooks Laboratories share news, announcements and annual reports
NSE: BROOKSBSE: 533543Pharmaceuticals & BiotechnologySmall Cap
Brooks Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 2011
Last close ₹60.56down ₹3.28 (5.14%)BSE ₹60.85
Share price at the NSE close on 30 Oct 2026. Previous close ₹63.84.
30 Oct: open ₹65.80, high ₹66.00, low ₹59.70
52-week range of traded prices to 30 Oct 2026
₹36.30Low, 30 Mar 2026₹116.00High, 31 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹178 Cr2,450th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 13.50
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.45
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 12.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.06
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 54,79557.7% delivered
Brooks Laboratories share news and announcements
454 announcements, routine notices left out, newest first. Page 9 of 10.
Feb 2014
13 Feb · Results
Nov 2013
14 Nov · Results
Oct 2013
3 Oct · Management
Resolution was passed by circulation effected on September 28, 2013 whereby Mr. Deepak Mahajan was appointed as Additional Independent Director with effect from September 28, 2013. Further, he has also been appointed as a member of Shareholders Grievances Committee and Remuneration Committee of the Board of Directors of the Company.
Sep 2013
10 Sep · Disclosure of Voting Pattern - Clause 35A
Aug 2013
14 Aug · Meeting
Register of Members and Share Transfer Books of the Company will remain closed from September 2, 2013 to September 5, 2013 (both days inclusive) for the purpose of Annual General Meeting of the Company scheduled to be held on September 6, 2013.12 Aug · Results
May 2013
30 May · Results
27 May · Management
Resolution was passed by circulation effected on 22.05.2013 whereby Mr. Bhaskar Sharma has been appointed as Additional Independent Director with effect from 22.05.2013. Further, he has also been appointed as a member of Audit Committee, Shareholders Grievances Committee and Remuneration Committee of the Board of Directors of the Company.20 May · Board meeting
To consider and to approve, inter alia, Audited Financial Results for the quarter and financial year ended March 31, 2013.
Apr 2013
3 Apr · Management
Following directors have resigned as Independent Director of the Company: (1) Mr. Anil Khanna; (2) Mr. Harsh Bhalla. The Board accepted their resignation in its meeting held on April 02, 2013 with effect from the date of the meeting.
Feb 2013
4 Feb · Board meeting
To consider and to approve, inter alia, unaudited Financial Results for the quarter ended December 31, 2012
Dec 2012
31 Dec · Management
Resolution was passed by circulation effected on October 16, 2012 whereby the resignation of Mr. Dinesh Puri from the post of Independent Director of the Company was accepted with immediate effect.24 Dec · Management
Resolution was passed by circulation effected on December 01,2012 whereby Mr. Harsh Bhalla was appointed as Additional Independent Director with effect from December 01,2012. Further, he has also been appointed as a member of Audit Committee and Shareholders' Grievances Committee of the Board of Directors of the Company.
Nov 2012
Oct 2012
31 Oct · Board meeting
To transact the following business : (1) To consider and to approve unaudited Financial Results for the quarter and half-year ended September 30, 2012; and (2) To transact any other business.
Sep 2012
26 Sep · Disclosure of Voting Pattern - Clause 35A
4 Sep · Meeting
Annual General Meeting of the Company will be held on September 25, 2012. Further the Register of Members and Share Transfer Book of the Company will remain closed from September 18, 2012 to September 25, 2012 for the purpose of Annual General Meeting of the Company.3 Sep · Address Change
Vide letter dated August 31, 2012 that the Registered Office of the Company has been shifted to Brooks Laboratories Limited, Village Kishanpura, Nalagarh Road , Baddi, Distt. Solan, Himachal Pradesh.
Aug 2012
29 Aug · Updates
Company had submitted application to the Company Law Board, New Delhi Bench for shifting of Registered Office of the Company from the State of Punjab to the State of Himachal Pradesh Under Section 17 of the Companies Act, 1956. The aforesaid Bench has accepted the application and an Order has been passed dated August 22, 2012 (Certified Copy of the Order being received on August 23, 2012) for confirming the alteration in Clause II of the Memorandum of Association of the Company.23 Aug · Board meeting
To transact the following businesses : (1) To approve the Annual Report of the Company carrying its Directors' Report, Management Discussion and Analysis and Cooperate Governance Report for the F.Y. 2011-12; (2) To issue Notice of forthcoming Annual General Meeting; (3) Any other business.14 Aug · Results
6 Aug · Board meeting
To transact the following business : (1) To consider and to approve un-audited Financial Results for the quarter ended June 30, 2012; and (2) To transact any other business.
Jun 2012
29 Jun · Board meeting
Meeting of the Board of Directors of the Company was held on June 28, 2012, wherein the following resolutions were passed unanimously: (1) To consider and approve the appointment of Mr. Anil Khanna as Additional Independent Director with immediate effect. (2) To consider and approve the re-appointment of Cost Auditor.
May 2012
29 May · Results
23 May · Board meeting
18 May · Board meeting
To transact the following business : (1) To consider and to approve audited Financial Results for the year ended March 31, 2012; and (2) To transact other routine businesses.3 May · Results
Company will submit annual audited financial results within 60 days from the end of fourth quarter alongwith Q4 results which would be a balancing figure i.e on or before May 30, 2012. Accordingly, the company does not propose to publish the unaudited financial results for the last quarter ended March 31, 2012.
Feb 2012
17 Feb · Board meeting
Board of Directors of the Company in their meeting held on February 15, 2012 discussed and decided the following matters: (1) Accepted the resignation of Company Secretary cum Compliance Officer of the Company w.e.f. February 06, 2012.8 Feb · Board meeting
To discuss and approve the unaudited provisional results for quarter ended December 31, 2011.
Jan 2012
30 Jan · Board meeting
Board of Directors of the Company in their meeting held on January 28, 2012, accept the resignation of below mentioned Directors w.e.f. January 06, 2012: (1) Vivek Sharma. (2) Lalit Mahajan. (3) Monika Sabharwal.25 Jan · Board meeting
To accept the resignation of Independent directors of the Company.9 Jan · Management
Below mentioned Independent Director of the Company have resigned from the company w.e.f. January 06, 2012: (1) Monika Sabharwal.(2) Vivek Sharma. (3) Lalit Mahajan.2 Jan · Updates
Vide its letter dated December 30, 2011 that the company has received an interim order from SEBI under Section 11 (1), 11 (4) , 11A and 11B of the SEBI Act,1992. The orders are being reviewed by the Company and will take necessary actions while keeping in mind the best interest of the investors .
Dec 2011
13 Dec · Board meeting
To discuss and decide the following business : (1) To consider and approve the alteration, amendment, variation and revision of site pertaining to the proposed project mentioned in the prospectus dated August 22, 2011; (2) To shift the registered office of the Company from one state to another state.
Nov 2011
21 Nov · Board meeting
Board of Directors in their meeting held on November 19, 2011, pursuant to the provisions of Section 295 of the Companies Act, 1956 and subject to the approval of the Central Government, sanction the proposal of making a loan of the maximum amount of Rs. 30000000/- (Three Crores only) each to Mr. Atul Ranchal, Chairman cum whole time director and Mr. Rajesh Mahajan, Managing Director of the Company.16 Nov · Board meeting
To discuss and decide regarding the loan to Mr. Rajesh Mahajan, Managing Director and Mr. Atul Ranchal, Whole time director of the company under Section 295 of the Companies Act, 1956.